The patient carrier of mechanical support to the circle: what every cardiologist should know for the management of acute problems

被引：1
作者：
Marini, Marco [1 ]
Raineri, Claudia [2 ]
Di Tano, Giuseppe [3 ]
Cipriani, Manlio [4 ]
Oliva, Fabrizio [4 ]
De Maria, Renata [5 ]
机构：
[1] AO Osped Riuniti, SC Cardiol, Dipartimento Cardiovasc, Ancona, Italy
[2] IRCCS Policlin San Matteo, Div Cardiol, Pavia, Italy
[3] Azienda Ist Ospitalieri, UO Cardiol, Largo Priori 1, I-26100 Cremona, Italy
[4] AO Osped Niguarda Ca Granda, SC Cardiol Insufficienza Cardiaca & Trapianto 2, Milan, Italy
[5] AO Osped Niguarda Ca Granda, Dipartimento Cardiotoracovasc, Ist Fisiol Clin, CNR, Milan, Italy
来源：
GIORNALE ITALIANO DI CARDIOLOGIA | 2013年 / 14卷 / 10期
关键词：
Complications; Heart failure; Mechanical circulatory support;
D O I：
10.1714/1335.14832
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Patients with advanced heart failure refractory to optimal medical treatment have a high mortality and a poor quality of life with frequent hospital admissions. The lack of alternative treatment options has prompted the development of mechanical circulatory support (MCS) devices, first as bridge to heart transplant and subsequently as destination therapy as a valid alternative to transplant. Last generation MCS devices are mechanically reliable and their management has become increasingly less complex. Nowadays, medium-term survival does not significantly differ between MCS and heart transplant recipients. MCS management programs require a multidisciplinary team to optimize the pathway leading to rehabilitation and improved quality of life and decrease the frequent occurrence of complications. However, in the near future with the growing number of implants, the chances for clinical cardiologists to come across a MCS recipient will increase. The management of general or acute problems will no longer be limited to tertiary implanting centers. A key issue to improve patient outcomes is the provision of a smooth and careful transition from the hospital environment to home care. The aim of this review is to start this process by providing basic notions and general indications through several scenarios of MCS recipients presenting to the emergency room for acute clinical problems.
引用
收藏
页码：659 / 668
页数：10
相关论文
共 60 条
[51]  
Cantillon D.J., Tarakji K.G., Kumbhani D.J., Smedira N.G., Starling R.C., Wilkoff B.L., Improved survival among ventricular assist device recipients with a concomitant im-plantable cardioverter-defibrillator, Heart Rhythm, 7, pp. 466-471, (2010)
[52]  
Fuster V., Ryden L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenbogen K.A., Halperin J.L., Le Heuzey J.-Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith S.C., Jacobs A.K., Adams C.D., Anderson J.L., Antman E.M., Halperin J.L., Hunt S.A., Nishimura R., Ornato J.P., Page R.L., Riegel B., Priori S.G., Blanc J.-J., Budaj A., Camm A.J., Dean V., Deckers J.W., Despres C., Dickstein K., Lekakis J., McGregor K., Metra M., Morais J., Osterspey A., Tamargo J.L., Zamo
[53]  
Adzic A., Patel S.R., Maybaum S., Impact of adverse events on ventricular assist device outcomes, Curr Heart Fail Rep, 10, pp. 89-100, (2013)
[54]  
Aggarwal A., Pant R., Kumar S., Et al., Incidence and management of gastrointestinal bleeding with continuous flow assist devices, Ann Thorac Surg, 93, pp. 1534-1540, (2012)
[55]  
Crow S., Chen D., Milano C., Et al., Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients, Ann Thorac Surg, 90, pp. 1263-1269, (2010)
[56]  
Meyer A.L., Malehsa D., Bara C., Et al., Acquired von Willebrand syndrome in patients with an axial flow left ventricular assist device, Circ Heart Fail, 3, pp. 675-681, (2010)
[57]  
Aaronson K.D., Slaughter M.S., Miller L.W., Et al., Use of an intrapericardial continuous-flow centrifugal pump in patients awaiting heart transplantation, Circulation, 125, pp. 3191-3200, (2012)
[58]  
John R., Kamdar F., Liao K., Et al., Low thromboembolic risk for patients with the HeartMate II left ventricular assist device, J Thorac Cardiovasc Surg, 136, pp. 1318-1323, (2008)
[59]  
Boyle A.J., Russell S.D., Teuteberg J.J., Et al., Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: Analysis of outpatient anti-coagulation, J Heart Lung Transplant, 28, pp. 881-887, (2009)
[60]  
Rogers J.G., Milano C.A., Ramping up evidence-based ventricular assist device care, J Am Coll Cardiol, 60, pp. 1776-1777, (2012)
123456